A detailed history of Lindbrook Capital, LLC transactions in Sana Biotechnology, Inc. stock. As of the latest transaction made, Lindbrook Capital, LLC holds 901 shares of SANA stock, worth $2,693. This represents 0.0% of its overall portfolio holdings.

Number of Shares
901
Previous 91 890.11%
Holding current value
$2,693
Previous $0 Infinity%
% of portfolio
0.0%
Previous 0.0%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Feb 06, 2025

BUY
$1.6 - $4.36 $1,296 - $3,531
810 Added 890.11%
901 $1,000
Q3 2024

Nov 01, 2024

BUY
$3.76 - $6.86 $342 - $624
91 New
91 $0
Q3 2023

Oct 25, 2023

BUY
$3.77 - $6.23 $490 - $809
130 Added 16.41%
922 $3,000
Q1 2023

Apr 26, 2023

BUY
$3.11 - $4.92 $2,463 - $3,896
792 New
792 $2,000
Q3 2022

Nov 10, 2022

BUY
$5.58 - $9.04 $1,305 - $2,115
234 New
234 $1,000

Others Institutions Holding SANA

About Sana Biotechnology, Inc.


  • Ticker SANA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 190,232,000
  • Market Cap $569M
  • Description
  • Sana Biotechnology, Inc., a biotechnology company, focuses on utilizing engineered cells as medicines. The company develops ex vivo and in vivo cell engineering platforms for various therapeutic areas with unmet treatment needs, including oncology, diabetes, central nervous system disorders, cardiovascular diseases, genetic disorders, and others...
More about SANA
Track This Portfolio

Track Lindbrook Capital, LLC Portfolio

Follow Lindbrook Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Lindbrook Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Lindbrook Capital, LLC with notifications on news.